The 2023 Guide To Implementing An Effective 340B Program

May 24, 2023340B, 340B ESP, Bedside Prescription Delivery, Compliance, Covered Entities, Drug Manufacturer Restrictions, Meds To Beds, PBM, Requirements, Specialty Drugs, Specialty Drugs, Specialty Pharmacy, Specialty Pharmacy, TPA / TPAs No Comments

The 340B-program landscape has changed dramatically. For the 340B program’s first 28 years after its 1992 inception, the basic list of Best Practices for eligible entities remained largely unchanged — aside from the dramatically-increased importance of using specialized software. But since the June, 2020 introduction of 340B ESP — which has led to an avalanche … Read More

How 340B Programs Can Positively Impact Value-Based Care Scores

March 9, 2023340B, Bedside Prescription Delivery, CMS Star Ratings, Covered Entities, Medicare, Medication Compliance, Meds To Beds, Meds To Beds, Outpatient Tracking, Overview, Patient Eligibility, Readmissions Reduction, Value-Based Care

It’s no secret that, for hospitals, one of the Affordable Care Act’s most far-reaching legacies is the impact that Value-Based Care has on the payments they receive. For many health systems, the lower their Value-Based Care scores, the lower the payments they receive from treating Medicare and Medicaid patients. What isn’t as commonly considered — … Read More

How To Manage A Director of Pharmacy’s Responsibilities And An Optimized 340B Program. Without Hiring More Staff.

November 9, 2022340B, 340B ESP, Bedside Prescription Delivery, Compliance, Contract Pharmacy, Meds To Beds, Outpatient Tracking, Patient Eligibility, Retail / Outpatient Pharmacy, Specialty Pharmacy

Two DOPs Deal With Operations, The 340B Program, And Drug Manufacturers’ Restrictions ProxsysRx recently organized an introductory Zoom meeting between the DOPs of two health systems we serve. Southwest Mississippi Regional Medical Center’s (SMRMC) Tiffany Poole earned her Doctorate of Pharmacy degree from the University of Mississippi in 2006. A ProxsysRx pharmacist since 2018, she … Read More

How Outpatient Pharmacies in Hospitals Impact the True Costs of Readmissions

May 31, 2022Bedside Prescription Delivery, CMS Star Ratings, Medication Compliance, Meds To Beds, Meds To Beds, Prescription Discounts, Readmissions, Readmissions Reduction, Retail / Outpatient Pharmacy

How can outpatient pharmacies reduce hospital readmissions? We’ve reported the following statistical finding elsewhere in this forum, but it bears repeating: Up to 70% of all preventable outpatient hospital readmissions are due to prescription non-compliance. Making matters worse for hospitals, the analytics generated by ProxsysRx’s proprietary software indicate that average hospital readmissions from prescription non-compliance … Read More

340B Best Practices You Need To Know

April 1, 2022340B, Audit, Bedside Prescription Delivery, Compliance, Contract Pharmacy, Covered Entities, Meds To Beds, Overview, Patient Eligibility, Requirements, Specialty Pharmacy, Specialty Pharmacy

If your hospital is 340B-eligible, you may be missing-out on millions of dollars in prescription reimbursements. Savings and revenue which, for some hospitals served by ProxsysRx, actually make the difference between solvency and closure. Any list of Best Practices for running a 340B program starts with maintaining compliance. Tips for maintaining 340B Program Compliance The … Read More

How Meds To Beds Can Drive Your 340B Savings

February 11, 2022340B, Bedside Prescription Delivery, Contract Pharmacy, Covered Entities, Meds To Beds

Getting started with the 340B Program 340B savings can mean potentially millions of dollars in retail and specialty prescription reimbursements annually. Savings and revenue which, for some hospitals, literally make the difference between solvency and closure. The first step in preparing your health system for enrollment in the 340B program is to ensure that you’re … Read More